Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

Legendary singer and actor Sir Cliff Richard has publicly spoken out about how he was diagnosed with prostate cancer after a ...

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.

PSA stands for prostate-specific antigen, a substance naturally produced in prostate tissue. A small amount of PSA regularly sneaks into the bloodstream, and low blood concentration is considered ...

In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.

A prostate cancer charity has voiced concerns regarding the planned introduction of at-home prostate-specific antigen (PSA) tests, urging for greater clarity on how men with the disease will utilise ...

A charity providing free prostate cancer tests has called for more NHS screening to reduce the number of men who go undiagnosed. The Torbay Prostate Support Association (TPSA) said men who had the ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.